DarioHealth President & CCO Steven Nelson departs Sept 1, 2026; consulting to 2027

DarioHealth Corp.

Ceases as President & Chief Commercial Officer effective Sept 1, 2026; employment terminates Sept 30, 2026.
Separation agreement: earned wages and health coverage through Sept 30; COBRA reimbursement of $2,600/month up to 3 months.
Consulting agreement Oct 1, 2026–Dec 31, 2027 grants 30,000 restricted shares (vest at 1-yr anniversary or change in control); 15,000 vest immediately if terminated early.
Outstanding unvested equity awards expire on termination; 6-month non-compete and 12-month non-solicitation apply.
He will cooperate with transition through Dec 31, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.